抗CD47（lemzoparlimab biosimilar）單克隆抗體,Anti-CD47 (lemzoparlimab biosimilar) monoclonal antibody 生命科學產品與技術服務-必威betway官方网站登录工程(上海)股份有限公司

Order NO. D146091

抗CD47（lemzoparlimab biosimilar）單克隆抗體

英文名	Anti-CD47 (lemzoparlimab biosimilar) monoclonal antibody
別名	CD47; TJ-011133; TJC-4
相關類別	IVD抗體原料	儲存	冷凍（-20℃）
宿主	Humanized	反應種屬	Human
標記物	Unconjugate	克隆類型	monoclonal
抗原	CD47

屬性

Background:	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Applications:	ELISA, FC
Name of antibody:	CD47
Common name:	TJ-011133, TJC-4
Synonyms:	CD47;MER6;IAP
SwissProt:	Q08722
ELISA Recommended dilution:	5000-10000
FC Recommended dilution:	50-100

相關文檔

Sample Application

ELISA plate pre-coated by 1 μg/mL (100 μL/well) Human CD47 protein, mFc-His Tag (Catalog number: D145739) can bind Anti-CD47 monoclonal antibody (Catalog number: D146091) in a linear range of 3.2-400 ng/mL.
Flow cytometry analysis of antigen binding of Anti-CD47 monoclonal antibody (Catalog number: D146091). A clear peak shift of D146091 was seen compared to the control when incubated with CD47-expressing 8226 cells, indicating strong binding of D146091 to CD47. Antibodies were incubated at 5 μg/mL.